InsiderClue
← All stocks

IOVANCE BIOTHERAPEUTICS, INC.

IOVA Net buying
CIK 0001425205 #1514 in the set updated 21 Sep 2026
Bought (120 mo)
$159.76M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$503.00K
$0.00 on a plan · $503.00K straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
+$159.26M
+$159.76M against sales at will

By person

13 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rothbaum Wayne P.
Director
$156.30M (7)
—
+$156.30M
28,067,333
6.20%
$51.64M
+380.1%
MCPEAK MERRILL A
Director
$2.76M (8)
—
+$2.76M
568,783
0.1256%
$1.05M
+172.4%
Dukes Iain D.
Director
$457.60K (3)
—
+$457.60K
54,000
0.0119%
$99.36K
—
Maynard Ryan D
Director
$50.59K (1)
$503.00K (1) scheduled
−$452.41K
7,500
0.0017%
$13.80K
—
WEISER MICHAEL
Director
$67.98K (2)
—
+$67.98K
112,632
0.0249%
$207.24K
+9.7%
Kirby Daniel Gordon
Chief Commercial Officer
$55.20K (1)
—
+$55.20K
154,511
0.0341%
$284.30K
—
Vogt Frederick G
Interim CEO & General Counsel
$54.67K (3)
—
+$54.67K
595,447
0.1315%
$1.10M
—
Puri Raj K.
Chief Regulatory Officer
$9.74K (1)
—
+$9.74K
256,364
0.0566%
$471.71K
+70.0%
Fardis Maria
President and CEO
—
—
—
298,786
0.0660%
$549.77K
−45.7%
BILINSKY IGOR
Chief Operating Officer
—
—
—
142,074
0.0314%
$261.42K
—
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
—
—
—
140,111
0.0309%
$257.80K
—
Bellemin Jean-Marc
Chief Financial Officer
—
—
—
60,529
0.0134%
$111.37K
—
Roche Corleen M.
Chief Financial Officer
—
—
—
28,757
0.0063%
$52.91K
—

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Kirby Daniel Gordon
5 Jun 2025
Chief Commercial Officer
Buy
30,000
$1.84
$55.20K
Puri Raj K.
23 May 2025
Chief Regulatory Officer
Buy
5,600
$1.74
$9.74K
Vogt Frederick G
14 May 2025
Interim CEO & General Counsel
Buy
25,000
$1.69
$42.25K
Rothbaum Wayne P.
20 Feb 2024
Director
Buy indirect
5,000,000
$9.15
$45.75M
Dukes Iain D.
20 Feb 2024
Director
Buy
32,000
$9.15
$292.80K
MCPEAK MERRILL A
20 Feb 2024
Director
Buy
250,000
$9.15
$2.29M
MCPEAK MERRILL A
18 Sep 2023
Director
Buy indirect
10,000
$5.56
$55.60K
Rothbaum Wayne P.
15 Sep 2023
Director
Buy indirect
5,000,000
$5.30
$26.50M
MCPEAK MERRILL A
21 Dec 2022
Director
Buy
10,000
$6.15
$61.50K
Rothbaum Wayne P.
2 Dec 2022
Director
Buy indirect
10,000,000
$6.50
$65.00M
MCPEAK MERRILL A
29 Nov 2022
Director
Buy indirect
10,000
$6.31
$63.10K
MCPEAK MERRILL A
28 Nov 2022
Director
Buy indirect
10,000
$6.18
$61.80K
Vogt Frederick G
28 Nov 2022
Interim CEO & General Counsel
Buy
1,000
$5.98
$5.98K
Dukes Iain D.
23 Nov 2022
Director
Buy
10,000
$6.10
$61.00K
Rothbaum Wayne P.
1 Jun 2022
Director
Buy indirect
500,000
$6.43
$3.22M
Vogt Frederick G
1 Jun 2022
Interim CEO & General Counsel
Buy
1,000
$6.44
$6.44K
Rothbaum Wayne P.
31 May 2022
Director
Buy indirect
500,000
$6.77
$3.38M
WEISER MICHAEL
31 May 2022
Director
Buy
7,813
$6.80
$53.13K
WEISER MICHAEL
31 May 2022
Director
Buy
2,187
$6.79
$14.85K
Maynard Ryan D
31 May 2022
Director
Buy
7,500
$6.75
$50.59K
MCPEAK MERRILL A
31 May 2022
Director
Buy indirect
10,000
$6.80
$68.00K
MCPEAK MERRILL A
31 May 2022
Director
Buy
10,000
$6.84
$68.40K
Dukes Iain D.
18 Dec 2018
Director
Buy
12,000
$8.65
$103.80K
MCPEAK MERRILL A
13 Dec 2018
Director
Buy
10,000
$9.63
$96.27K
Rothbaum Wayne P.
6 Dec 2018
Director
Buy indirect
300,000
$9.86
$2.96M
Rothbaum Wayne P.
4 Dec 2018
Director
Buy indirect
921,053
$10.31
$9.50M
Show all 28 transactions →

What was left out

Form 4 filings counted 232
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,348,972
History held since 15 Nov 2016